CISCRP (Center for Information & Study on Clinical Research Participation) Boosts Awareness of Clinical Trials with AWARE Northeast Virtual Event
Share Article
The nonprofit organization scales interest by providing educational information about clinical research participation through free, interactive, online educational events. Patients and medical professionals share their stories and perspectives about clinical trials. Community events like AWARE help bring information about clinical research and the benefits of participating in it, says AWARE for All - Northeast panelist, Christian Ramirez Martinez, Clinical Research Enrollment Manager at Columbia University Irving Medical Center’s All of Us Research Program. BOSTON (PRWEB) April 12, 2021 CISCRP (Center for Information & Study on Clinical Research Participation), a nonprofit organization dedicated to engaging the public and patients as partners in the c
Columbia University Irving Medical Center
Several faculty and staff members representing Columbia University Irving Medical Center participated in videos produced to encourage their fellow New Yorkers to get vaccinated against COVID-19.
Their stories, captured in 30- to 60-second videos, will be broadcast on major networks starting this week as part of “Roll Up Your Sleeves NY,” a COVID-19 public education campaign spearheaded by the New York governor’s office.
Their videotaped responses reveal why they chose to be vaccinated. “Because I’m ready to not be afraid,” says one CUIMC employee. “Because I do not want anyone else to lose a loved one the way that I did,” says another.
30 Stocks Moving in Friday s Pre-Market Session Benzinga 3 hrs ago
Gainers
Celcuity Inc. (NASDAQ: CELC) rose 32.3% to $19.00 in pre-market trading after the company reported a worldwide licensing agreement with Pfizer to develop and commercialize gedatolisib. The company also reported preliminary data from Phase 1b Trial of gedatolisib plus ibrance and endocrine therapy for patients with ER+/HER2- metastatic breast cancer.
Gulf Resources, Inc. (NASDAQ: GURE) rose 29.5% to $6.02 in pre-market trading after the company reported a narrower loss for the fourth quarter.
TherapeuticsMD, Inc. (NASDAQ: TXMD) rose 19% to $1.57 in pre-market trading after the company, and Theramex, announced the approval of BIJUVE capsules indicated for hormone replacement therapy in the U.K. and under the trade name BIJUVA in Belgium.
E-Mail
In a study of over 73 million delivery hospitalizations during a 19-year period in the United States, researchers at Columbia University Mailman School of Public Health and Columbia University Irving Medical Center found that failure to rescue from severe maternal morbidity contributes more than a half of the 3-fold difference in maternal mortality between Black women and White women. Failure to rescue refers to death resulting from severe maternal morbidity such as eclampsia, acute heart failure, and sepsis. The findings are published in the journal
Obstetrics and Gynecology. Despite the continuing decrease in failure to rescue over the entire study period, racial and ethnic disparities in failure to rescue persisted, underscoring the need to identify factors accounting for these disparities and to identify interventions to avoid potentially preventable deaths in racial and ethnic minority women, said Jean Guglielminotti, MD, PhD, in the Department of Anesthesiology
Aurinia Presents Data Demonstrating LUPKYNIS™ (voclosporin) Efficacy Across Lupus Nephritis Biopsy Classes at National Kidney Foundation 2021 Spring Clinical Meetings streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.